BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23422243)

  • 1. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
    Skog O; Korsgren S; Melhus A; Korsgren O
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):118-23. PubMed ID: 23422243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for immune intervention trials in type 1 diabetes.
    Mallone R; Roep BO
    Clin Immunol; 2013 Dec; 149(3):286-96. PubMed ID: 23510725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut as a regulator of early inflammation in type 1 diabetes.
    Vaarala O
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):241-7. PubMed ID: 21681088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
    Planas R; Pujol-Borrell R; Vives-Pi M
    Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pancreas in human type 1 diabetes: providing new answers to age-old questions.
    Atkinson MA; Gianani R
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):279-85. PubMed ID: 19502978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What causes type 1 diabetes? Lessons from animal models.
    Buschard K
    APMIS Suppl; 2011 Jul; (132):1-19. PubMed ID: 21615797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils and type 1 autoimmune diabetes.
    Battaglia M
    Curr Opin Hematol; 2014 Jan; 21(1):8-15. PubMed ID: 24275691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes.
    Vecchio F; Messina G; Giovenzana A; Petrelli A
    Curr Diab Rep; 2019 Aug; 19(10):92. PubMed ID: 31471779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.
    Elo LL; Mykkänen J; Nikula T; Järvenpää H; Simell S; Aittokallio T; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O; Lahesmaa R
    J Autoimmun; 2010 Aug; 35(1):70-6. PubMed ID: 20356713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells and type 1 diabetes.
    Rodacki M; Milech A; de Oliveira JE
    Clin Dev Immunol; 2006; 13(2-4):101-7. PubMed ID: 17162353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic basis for type 1 diabetes.
    Mehers KL; Gillespie KM
    Br Med Bull; 2008; 88(1):115-29. PubMed ID: 19088009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
    Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
    Lee MH; Lee WH; Todorov I; Liu CP
    J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for an autoimmune aetiology of type 1 diabetes.
    Mannering SI; Pathiraja V; Kay TW
    Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.